Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

Market Cap	9.61B
Revenue (ttm)	9.03B
Net Income (ttm)	472.01M
Shares Out	689.78M
EPS (ttm)	0.67
PE Ratio	9.33
Forward PE	17.03
Dividend	0.30 (4.80%)
Ex-Dividend Date	Sep 4, 2024

Volume	62,500,200
Average Volume	4,391,600
Open	5.85
Previous Close	5.70
Day's Range	5.85 - 6.60
52-Week Range	5.00 - 8.05
Beta	-0.07
RSI	77.00
Earnings Date	Aug 20, 2025

About HKG:0719

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. The company also provides ibuprofen bulk pharmaceutical products; a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 7,296
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0719

Financial Performance

In 2024, HKG:0719's revenue was 8.47 billion, an increase of 4.51% compared to the previous year's 8.10 billion. Earnings were 470.02 million, a decrease of -5.33%.

Financial numbers in CNY